Peer-reviewed veterinary case report
Muscle disease with sugar buildup in a Springer Spaniel dog
By Harvey, J W et al.·Published in Veterinary pathology·1990·Department of Physiological Sciences, United States·View original on PubMed →
PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →
Original publication title: Polysaccharide storage myopathy in canine phosphofructokinase deficiency (type VII glycogen storage disease).
- Species:
- dog
Plain-English summary
An 11-year-old male English Springer Spaniel developed severe muscle weakness due to a rare condition called phosphofructokinase deficiency, which affects how muscles store energy. Despite normal neurological exam results, tests on the dog's muscle tissue showed unusual deposits that indicated a problem with energy storage. Unfortunately, there is no specific treatment for this condition, and the dog's muscle function continued to decline. Owners of dogs with similar symptoms should consult their veterinarian for guidance on managing muscle health and energy levels.
People also search for: dog muscle weakness treatment · phosphofructokinase deficiency in dogs · English Springer Spaniel muscle problems
Abstract
A severe, progressive myopathy developed in an 11-year-old, phosphofructokinase (PFK)-deficient, male, English Springer Spaniel dog. Results from a routine neurological examination were normal. Examination of histologic sections of skeletal muscle revealed large accumulations of material in some myofibers. These deposits were pale, basophilic, somewhat flocculent, and slightly granular with hematoxylin and eosin stain. Most fascicles examined in sections of limb and trunk muscles were affected to some degree, with up to 10% of muscle fibers being involved. Deposits stained strongly with periodic acid-Schiff and were resistant to digestion by alpha amylase but were removed by incubation with gamma amylase. Deposits were faintly positive with Gomori's methenamine silver technique and alcian blue (pH 2.5) and were brown-gray with Lugol's iodine solution but were negative with other stains. Based on staining characteristics, the deposits seemed to consist primarily of an amylopectin-like polysaccharide(s). Alcian blue staining (pH 2.5) was removed by treatment with neuraminidase but not with hyaluronidase, indicating that some sialic acid residues were also present. Electron microscopically, the deposits were composed of short granular filaments, small granules and amorphous material. They were not membrane bound. The morphologic appearance and staining characteristics of the deposits were remarkably similar to deposits previously described in human PFK-deficient myopathy. As expected, total PFK activities were markedly reduced when assayed in skeletal muscles of this dog. In contrast with other PFK-deficient dogs, muscle glycogen in this animal was not increased above that of normal dogs.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/2137952/